Company news
Myriad Genetics, Inc. news in 2021
Myriad Genetics, Inc.'s news releases, calls and decks from 2021, newest first.
The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults
December 14, 2021
New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey
December 14, 2021
Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer
December 13, 2021
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment
November 21, 2021
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
November 1, 2021
Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021
October 26, 2021
Myriad Genetics Names Pamela Wong as Chief Legal Officer
October 17, 2021
Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing Business to LabCorp
September 12, 2021
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
August 2, 2021
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
August 1, 2021
Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021
July 27, 2021
Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities
July 20, 2021
Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions
June 30, 2021
Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
June 15, 2021
Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences
May 31, 2021
Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions
May 23, 2021
Myriad Genetics Appoints Melissa Gonzales to Lead Women’s Health Business
May 19, 2021
Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
May 18, 2021
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp
May 2, 2021
Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021
April 26, 2021
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
March 28, 2021
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
March 1, 2021
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
February 22, 2021
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
February 15, 2021
Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
February 1, 2021
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
January 10, 2021
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
January 4, 2021
Calls in 2021
Decks in 2021
- Q2 FY2021 Earnings Presentation
Earnings · 19 slides · Feb 23, 2021